The use of high‐dose immunoglobulin M‐enriched human immunoglobulin in dogs with immune‐mediated hemolytic anemia

BACKGROUND: The IV use of human immunoglobulin (hIVIG) in dogs with primary immune‐mediated hemolytic anemia (IMHA) has been described previously, but herein we describe the use of high‐dose IgM‐enriched hIVIG (Pentaglobin). HYPOTHESIS/OBJECTIVES: Dogs treated with high‐dose Pentaglobin will experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Bestwick, Jason P., Sharman, Mellora, Whitley, Nat T., Kisielewicz, Caroline, Skelly, Barbara J., Tappin, Simon, Kellett‐Gregory, Lindsay, Seth, Mayank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783326/
https://www.ncbi.nlm.nih.gov/pubmed/34779044
http://dx.doi.org/10.1111/jvim.16315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783326/
https://www.ncbi.nlm.nih.gov/pubmed/34779044
http://dx.doi.org/10.1111/jvim.16315

Ejemplares similares